Search

everythinglearnresearchcommunity

for

Search:↓

Sensitive scalp causes discomfort and hair loss, treated with personalized care.

The skin conditions of Iraqi women changed during the COVID-19 pandemic, with more hair loss and skin irritation but fewer contagious skin infections.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

In Poland, people search more for certain skin conditions depending on the season, and despite more STD infections, searches for them have decreased, suggesting a need for better sexual education.

The COVID-19 pandemic led to more hair loss and skin irritation among Iraqi women, with some skin conditions increasing and others decreasing.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

Skin problems like rashes and hair loss can help diagnose and predict COVID-19.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Tofacitinib is an effective and safe treatment for alopecia areata.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

About 61% of women who had COVID-19 experienced hair loss afterward.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Tinea capitis should be considered in adults with scalp issues for proper treatment.

Human skin xenografting could improve our understanding of skin development, renewal, and healing.

Most postmenopausal women experience significant skin changes and various skin conditions.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

New understanding and treatments for hair loss are improving, but more research is needed.

The conclusion is that dermatologists need to improve prescription practices to reduce errors and drug interaction risks.

Neuropathic pruritus is a commonly overlooked and wrongly diagnosed type of chronic itching that is hard to treat.

An old recipe called "Champigny Saumure" might help treat a rare scalp condition.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

Some treatments for hair loss, like finasteride, biotin, and minoxidil, can be effective, but their success varies by individual case.

Isotretinoin effectively treated a rare scalp condition, but careful drug monitoring and a dairy-free diet were important.

During the COVID-19 pandemic, Iraqi women experienced more hair loss and certain skin conditions, while contagious skin infections decreased.

Botulinum Neurotoxin-A can treat acne, oily skin, rosacea, hair loss, prevent scars, relieve nerve pain, reduce excessive sweating, and manage psoriasis, but more trials are needed to confirm its effectiveness.

COVID-19 patients with skin signs often stayed in the hospital for less time than those without skin signs.

HIV patients in Korea often have skin diseases like fungal infections, folliculitis, and seborrheic dermatitis, which are less common with effective HIV treatment.